About: COVID-19 and myocarditis: What do we know so far?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 and myocarditis: What do we know so far? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 and myocarditis: What do we know so far?
Creator	Moeller, Andrew Mokhtar, Ahmed Pirzada, Ashar
Source	Elsevier; Medline; PMC
abstract	COVID-19 has been declared a global pandemic by the World Health Organization and is responsible for hundreds of thousands of deaths worldwide. COVID-19 is caused by SARS-CoV-2, and common clinical symptoms include fever, cough, sore throat, headache, and fatigue. Myocardial injury is relatively common in COVID-19, accounting for 7-23% of cases, and is associated with a higher morbidity and mortality. There is a discrepancy in the literature about myocarditis as the etiology of myocardial injury in COVID-19; although many anecdotal reports of myocarditis have been noted, there are only a handful of case reports in the literature about myocarditis related to COVID-19. This review summarizes the most up-to-date literature around the association between COVID-19 and myocarditis and gives clinicians a practical framework about the clinical manifestations, diagnostic tools and treatment options currently available. Importantly, this review will heighten suspicion for myocarditis as an etiology of myocardial injury in COVID-19 patients, therefore improving clinical outcomes and encouraging shared clinical decision-making. This will also open the door for further research to build around this review. Emergent treatment options for COVID-19 are in clinical trials and may be of benefit to COVID-19 patients with myocarditis in addition to current guideline-based recommendations.
has issue date	2020-05-28(xsd:dateTime)
bibo:doi	10.1016/j.cjco.2020.05.005
bibo:pmid	32691024
has license	no-cc
sha1sum (hex)	7aa65c8c30f7a2f84a3616795d8bb4742bdc0935
schema:url	https://doi.org/10.1016/j.cjco.2020.05.005
resource representing a document's title	COVID-19 and myocarditis: What do we know so far?
has PubMed Central identifier	PMC7254016
has PubMed identifier	32691024
schema:publication	CJC Open
resource representing a document's body	covid:7aa65c8c30f7a2f84a3616795d8bb4742bdc0935#body_text
is schema:about of	named entity 'responsible' named entity 'management' named entity 'circulatory support' named entity 'diagnosis' named entity 'COVID-19' named entity 'LIMITED' named entity 'MORTALITY' named entity 'RESPONSIBLE' named entity 'ECGs' named entity 'Investigations' named entity 'heart failure' named entity 'high' named entity 'COVID-19' named entity 'echocardiography' named entity 'infection' named entity 'COVID' named entity 'index of suspicion' named entity 'supportive care' named entity 'circulatory support' named entity 'heart failure' named entity 'COVID-19' named entity 'troponin' named entity 'COVID-19' named entity 'echocardiography' named entity 'heart failure' named entity 'post-mortem' named entity 'COVID' named entity 'Myocardial injury' named entity 'COVID-19' named entity 'Antiviral therapy' named entity 'myocarditis' named entity 'myocardial injury' named entity 'steroids' named entity 'echocardiography' named entity 'Heart failure symptoms' named entity 'antiviral therapy' named entity 'critically ill' named entity 'COVID-19' named entity 'inflammation' named entity 'COVID-19' named entity 'Wuhan University' named entity 'clinical trials' named entity 'fulminant' named entity 'alveolar' named entity 'Cytokine storm' named entity 'pathology' named entity 'COVID' named entity 'Antiviral therapy' named entity 'case series' named entity 'COVID-19' named entity 'sudden cardiac death' named entity 'BICC' named entity 'global pandemic' named entity 'prednisone' named entity 'CMR' named entity 'COVID-19' named entity 'fulminant' named entity 'ventricular arrhythmias' named entity 'ECG' named entity 'heart tissue' named entity 'myocardial infarction' named entity 'SARS-CoV-2' named entity 'RCT' named entity 'myalgia' named entity 'COVID' named entity 'echocardiography' named entity 'Myocarditis' named entity 'acute lung injury' named entity 'myocarditis' named entity 'cardiogenic shock' named entity 'cohort study' named entity 'ECG' named entity 'lung injury' named entity 'cough' named entity 'non-ischemic' named entity 'ventricular arrhythmias' named entity 'heart transplantation' named entity 'ventricular arrhythmias' named entity 'myocarditis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software